Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Odile Launay

Showing results (291-300 of 305) with videos related to

Pageof 31
Sort By:
Influenza and Other Respiratory Viruses|November 25, 2025
COVID-19 Vaccine Effectiveness Against Hospitalization in Older Adults, VEBIS Hospital Network, Europe, September 2024-May 2025Madelyn Rojas-Castro, Nuno Verdasca, Susana Monge, et al.
JMIR Public Health and Surveillance|April 4, 2024
Perspectives of European Patient Advocacy Groups on Volunteer Registries and Vaccine Trials: VACCELERATE Survey StudySophia Themistocleous, Christos D Argyropoulos, Paris Vogazianos, et al.
International Journal of Epidemiology|February 20, 2014
Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4)Murielle Mary-Krause, Sophie Grabar, Laurence Lièvre, et al.
Eclinicalmedicine|August 3, 2023
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group studyGuy de Bruyn, Joyce Wang, Annie Purvis, et al.
BMC Medicine|November 4, 2025
Vaccine effectiveness against influenza A in older adults and the effect of chronic conditions: results from the I-MOVE and VEBIS multicentre European hospital case-control studies, 2015/16-2023/24Angela Mary Catherine Rose, Nathalie Nicolay, Clara Mazagatos, et al.
Vaccine|May 20, 2023
VACCELERATE Site Network: Real-time definition of clinical study capacity in EuropeJon Salmanton-García, Pauline Wipfler, Paula Valle-Simón, et al.
Research Square|November 24, 2025
Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccinesAgathe Carrier, Paolo Manghi, Carolina Alves Costa Silva, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 28, 2021
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19Florence Ader, Nathan Peiffer-Smadja, Julien Poissy, et al.
Vaccine|June 6, 2022
VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolmentJon Salmanton-García, Fiona A Stewart, Sarah Heringer, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 24, 2023
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021Angela Mc Rose, Nathalie Nicolay, Virginia Sandonis Martín, et al.
Pageof 31

Showing results (291-300 of 305) with videos related to

Sort By:
Pageof 31
Influenza and Other Respiratory Viruses|November 25, 2025
COVID-19 Vaccine Effectiveness Against Hospitalization in Older Adults, VEBIS Hospital Network, Europe, September 2024-May 2025Madelyn Rojas-Castro, Nuno Verdasca, Susana Monge, et al.
JMIR Public Health and Surveillance|April 4, 2024
Perspectives of European Patient Advocacy Groups on Volunteer Registries and Vaccine Trials: VACCELERATE Survey StudySophia Themistocleous, Christos D Argyropoulos, Paris Vogazianos, et al.
International Journal of Epidemiology|February 20, 2014
Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4)Murielle Mary-Krause, Sophie Grabar, Laurence Lièvre, et al.
Eclinicalmedicine|August 3, 2023
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group studyGuy de Bruyn, Joyce Wang, Annie Purvis, et al.
BMC Medicine|November 4, 2025
Vaccine effectiveness against influenza A in older adults and the effect of chronic conditions: results from the I-MOVE and VEBIS multicentre European hospital case-control studies, 2015/16-2023/24Angela Mary Catherine Rose, Nathalie Nicolay, Clara Mazagatos, et al.
Vaccine|May 20, 2023
VACCELERATE Site Network: Real-time definition of clinical study capacity in EuropeJon Salmanton-García, Pauline Wipfler, Paula Valle-Simón, et al.
Research Square|November 24, 2025
Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccinesAgathe Carrier, Paolo Manghi, Carolina Alves Costa Silva, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 28, 2021
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19Florence Ader, Nathan Peiffer-Smadja, Julien Poissy, et al.
Vaccine|June 6, 2022
VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolmentJon Salmanton-García, Fiona A Stewart, Sarah Heringer, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 24, 2023
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021Angela Mc Rose, Nathalie Nicolay, Virginia Sandonis Martín, et al.
Pageof 31